XE variant of coronavirus no more serious than Omicron: Gagandeep Kang


The new XE variant of the coronavirus is not a cause for concern as it is not likely to cause more severity than other Omicron subvariants, Dr Gagandeep Kang, a professor at Christian Medical College Vellore, said on Thursday.

”Variations will come because people travel. What we know from the (XE) variant is that it’s not a concern,” Kang said.

“We were worried about BA.2 but he didn’t cause any more severe illness than BA.1. XE does not cause more severe disease than BA.1 or BA.2 (sub-variants of Omicron),” she said on the sidelines of a panel discussion organized by the Gupta-Klinsky India Institute of Johns Hopkins University here.

She added that in a vaccinated population, the XE variant is not something to worry about. The World Health Organization (WHO) has issued a warning against XE, a new variant of Omicron first detected in the UK.

He suggested it may be more transmissible than any strain of Covid so far. XE is a combination or recombinant of the two sub-variants (BA.1 and BA.2) of Omicron.

The Brihanmumbai Municipal Corporation (BMC) said it detected India’s first case of XE infection in Mumbai.

However, the Union Health Ministry said the sample believed to be the ‘XE’ variant was analyzed in detail by genome experts from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), who have deduces that the genomic constitution of this variant does not correspond to the genomic constitution of the XE variant.

Asked about her views on giving a booster dose to people under 60, Kang said the country does not have enough data to establish the effectiveness of booster doses in people. under 60 years old.

Indian Council of Medical Research (ICMR) Director General Balram Bhargava echoed a similar view on the booster dose and said, “I agree with Dr Kang. The roundtable was held under the theme “Applying lessons learned from COVID for a stronger health system.”” Dr Bhargava said the biggest thing India learned from Covid was that it became confident.

“We have confidence in the capacity of our health care system,” he said.

He acknowledged the need to strengthen the primary health care system to deal with such situations in the future.

”We need to invest more in the primary health care system and provide good training which is essential. We need good MBBS doctors with good rain,” Bhargava said.

He also said there was a need to raise awareness about the disease and the cure.

Speaking on the occasion, Amitabh Kant, CEO of NITI Aayog, said the pandemic has shown the need for efficient healthcare delivery.

”The need of the hour is technology and research solutions that quickly deliver data-driven insights so we can make informed health decisions quickly, both during a pandemic and for health issues. ongoing health. With our collective focus, this can really grow in India,” he said.

Chief of the Division of Infectious Diseases at Johns Hopkins University School of Medicine, Amita Gupta, said a multi-pronged approach is needed to deal with pandemic-like situations in the future. “We need to invest more in science. We need government, private sector and civil society to come together and be ready to deliver primary health care. India and the United States still have a long way to go. journey to make things better in the public health workforce,” Gupta said.

Public Health Foundation of India Chairman Srinath Reddy said the country needs a system that can deliver comprehensive healthcare. “The primary health care system must be strong enough that we don’t miss opportunities for early detection and treatment,” he said.

Founding Chairman and CEO of Medanta, Dr Naresh Trehan, said no country could ever have been prepared for such a disaster.

”Predicting and preventing is better than curing and repenting. There are over a lakh of ASHA workers. It is an important resource that remains underutilized. We have to give them good training,” Trehan said.

(This story has not been edited by the Devdiscourse team and is auto-generated from a syndicated feed.)


Comments are closed.